Cortisol
Also known as: hydrocortisone, glucocorticoid, compound F
The principal glucocorticoid, secreted by the zona fasciculata under ACTH control in a circadian rhythm, that mobilises fuel during fasting and stress, maintains blood pressure, and restrains inflammation and immunity.
Overview
Cortisol is a C21 steroid synthesised on demand from cholesterol. About 90–95 % is bound in plasma, mainly to corticosteroid-binding globulin (CBG, transcortin) and albumin; the free fraction (≈5–10 %) is active. It diffuses into cells and binds the cytoplasmic glucocorticoid receptor (GR), which sheds heat-shock proteins, moves to the nucleus and activates genes with glucocorticoid response elements or represses pro-inflammatory transcription factors (NF-κB, AP-1).
Metabolic actions (anti-insulin, fuel-mobilising): increased hepatic gluconeogenesis (induction of PEPCK, glucose-6-phosphatase) and glycogen storage; muscle protein breakdown supplying amino acids; lipolysis with redistribution of fat to the trunk and face; reduced peripheral glucose uptake. Cardiovascular: permissive for catecholamine vasoconstriction (α1-receptor expression) — essential to maintain blood pressure. Anti-inflammatory and immunosuppressive: induces annexin-1 (inhibiting phospholipase A₂), suppresses COX-2, cytokines (IL-1, IL-2, TNF-α) and histamine release; causes lymphopenia and eosinopenia but neutrophilia (demargination). Other: bone loss (inhibits osteoblasts and intestinal Ca²⁺ absorption), impaired wound healing and collagen synthesis (thin skin, striae), mood and memory effects, increased free-water clearance, surfactant production and maturation of the fetal lung.
In the kidney, the enzyme 11β-hydroxysteroid dehydrogenase type 2 converts cortisol to inactive cortisone, protecting the mineralocorticoid receptor (which binds cortisol as avidly as aldosterone) from the 100–1000-fold higher cortisol concentration.
- Location
Source: zona fasciculata of the adrenal cortex. Targets: virtually all cells (liver, muscle, adipose tissue, immune cells, vasculature, bone, brain).
Function
- Raises blood glucose by gluconeogenesis and insulin antagonism.
- Mobilises amino acids and fatty acids.
- Maintains vascular tone and blood pressure (permissive effect).
- Suppresses inflammation and immune responses.
- Supports the response to stress; matures the fetal lung.
- Physiology
Class: steroid (C21 glucocorticoid). Receptor: cytoplasmic/nuclear glucocorticoid receptor (NR3C1). Half-life ≈60–90 min. Binding: CBG ≈75–80 %, albumin ≈15 %, free ≈5–10 %. Secretion ≈10–20 mg/day.
- Regulation
ACTH (from CRH and ADH) stimulates; cortisol inhibits CRH and ACTH. Circadian rhythm: peak in the early morning, around waking; nadir around midnight. Stress (trauma, surgery, infection, hypoglycaemia) overrides feedback and rhythm.
Clinical significance
Excess — Cushing syndrome
Central obesity, moon face, buffalo hump, purple striae, bruising, proximal myopathy, osteoporosis, hypertension, diabetes, infections, depression. Most often iatrogenic (glucocorticoid therapy).
Deficiency — adrenal insufficiency
Primary (Addison) or secondary (pituitary/steroid withdrawal): fatigue, weight loss, hypotension, hypoglycaemia, hyponatraemia; adrenal crisis requires immediate hydrocortisone. Patients on steroids need "sick-day rules" (double dose during illness).
Apparent mineralocorticoid excess
Inhibition (liquorice — glycyrrhetinic acid) or genetic deficiency of 11β-HSD2 lets cortisol activate renal mineralocorticoid receptors → hypertension, hypokalaemia, low renin and low aldosterone. Very high cortisol (ectopic ACTH) saturates the enzyme with the same effect.
Test yourself
Why does the adrenal medulla secrete mainly epinephrine rather than norepinephrine?
- Chromaffin cells lack dopamine β-hydroxylase
- Cortisol reaching the medulla via the intra-adrenal portal circulation induces PNMT
- Aldosterone activates tyrosine hydroxylase
- Preganglionic fibres release epinephrine directly
Answer: Cortisol reaching the medulla via the intra-adrenal portal circulation induces PNMT
Cortisol-rich blood draining from the cortex into medullary sinusoids induces phenylethanolamine N-methyltransferase, which methylates norepinephrine to epinephrine. Extra-adrenal paragangliomas, lacking this cortisol exposure, secrete mainly norepinephrine.
A patient with ACTH-dependent Cushing syndrome shows suppression of cortisol with high-dose dexamethasone. The most likely source is:
- Adrenal cortical adenoma
- Pituitary corticotroph adenoma
- Ectopic ACTH from small-cell lung carcinoma
- Exogenous prednisolone
Answer: Pituitary corticotroph adenoma
Pituitary corticotroph adenomas retain partial glucocorticoid feedback and usually suppress at high dexamethasone doses; ectopic ACTH tumours do not. Adrenal tumours and exogenous steroids are ACTH-independent (ACTH suppressed).
Compiled from standard anatomy and physiology references — see the Endocrine System sources. For education only; not medical advice.